top of page

Elsee Medicine Reproductive Health Genomics Testing: Empowering Early Detection and Treatment of Infertility and Reproductive Health Disorders

Reproductive health is a critical aspect of overall health and wellbeing. Infertility and reproductive health disorders can have a significant impact on a person's quality of life, relationships, and mental health. Reproductive health genomics testing is a powerful tool that can identify genetic variations that increase the risk of infertility and reproductive health disorders, enabling early detection and treatment.

 

Reproductive health genomics testing involves analyzing a person's DNA to identify genetic variations that are associated with an increased risk of infertility and reproductive health disorders. By understanding a person's genetic makeup, doctors can personalize preventative strategies and interventions, potentially reducing the risk of these disorders.

 

Here are some of the key benefits of reproductive health genomics testing:

 

  • Early detection: Reproductive health genomics testing can identify genetic variations that increase the risk of infertility and reproductive health disorders. Armed with this information, doctors can implement preventative measures before the disorder progresses, potentially improving the chances of successful treatment.

  • Personalized treatment plans: Reproductive health genomics testing can help doctors tailor treatment plans to a patient's specific genetic makeup. This can lead to more effective treatments with fewer side effects.

  • Improved accuracy: Reproductive health genomics testing can help doctors distinguish between different types of infertility and reproductive health disorders, which can be difficult to do with traditional methods. This can improve the accuracy of diagnosis and treatment.

  • Better understanding of infertility and reproductive health disorders: By analyzing the DNA of patients with these disorders, reproductive health genomics testing can help researchers better understand the underlying mechanisms of the disorders. This can lead to the development of new treatments and prevention strategies.

  • Reduced healthcare costs: By identifying the most effective treatment plan for a patient, reproductive health genomics testing can reduce healthcare costs by minimizing the need for ineffective treatments or hospitalizations.

 

If you have concerns about your reproductive health or have experienced infertility or reproductive health disorders in the past, talk to your doctor about reproductive health genomics testing. It could provide valuable information that can improve your treatment options, reduce your risk of infertility and reproductive health disorders, and ultimately, improve your quality of life.

bigstock-Doctor-And-Young-Couple-8054842

  • Elsee Medicine is proud to offer Medical Genetics and Genomics Test for Reproductive Health and Fertility. Our test uses the most advanced Next-Generation Sequencing technology to analyze whole exome (the protein-encoding regions of 24,000 genes) with high coverage of up to 200X and a focused analysis on 356 major genes involved in reproductive health and fertility.

​

  • Our genomics tests are performed on CLIA-certified and CAP-certified genomic testing pipelines. Genomics data are analyzed by American certified medical geneticists (Fellows of American College of Medical Genetics and Genomics) and include the following major genetic conditions related to reproductive health (but not limited to):

    1. 11-beta-hydroxylase deficiency 

    2. 17-alpha-hydroxylase deficiency 

    3. 17-beta hydroxysteroid dehydrogenase 3 deficiency 

    4. 3-beta-hydroxysteroid dehydrogenase deficiency 

    5. 47 XXX syndrome 

    6. 5-alpha reductase deficiency 

    7. Achard Thiers syndrome

    8. Acro-pectoro-renal field defect 

    9. Acromegaly 

    10. ACTH-independent macronodular adrenal hyperplasia 

    11. ACTH-secreting pituitary adenoma 

    12. Acute fatty liver of pregnancy 

    13. Addison's disease 

    14. Adrenocortical carcinoma 

    15. Alpha-thalassemia x-linked intellectual disability syndrome 

    16. Aromatase deficiency 

    17. Aromatase excess syndrome 

    18. Asherman's syndrome 

    19. Ataxia - hypogonadism - choroidal dystrophy 

    20. Bardet-Biedl syndrome 

    21. Bardet-Biedl syndrome 1 

    22. Bardet-Biedl syndrome 10 

    23. Bardet-Biedl syndrome 11 

    24. Bardet-Biedl syndrome 12 

    25. Bardet-Biedl syndrome 2 

    26. Becker nevus syndrome 

    27. Benign mesonephroma 

    28. BRCA1 hereditary breast and ovarian cancer syndrome 

    29. BRCA2 hereditary breast and ovarian cancer syndrome 

    30. Campomelic dysplasia 

    31. Cerebellar ataxia and hypogonadotropic hypogonadism 

    32. CHARGE syndrome 

    33. Combined pituitary hormone deficiencies, genetic forms 

    34. Complete androgen insensitivity syndrome 

    35. Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency 

    36. Currarino triad 

    37. Cushing's syndrome 

    38. Denys-Drash syndrome 

    39. Diabetic mastopathy 

    40. Diethylstilbestrol syndrome 

    41. Extramammary Paget disease 

    42. Familial breast cancer - Not a rare disease 

    43. Follicle-stimulating hormone deficiency, isolated 

    44. Fowler's syndrome 

    45. Frasier syndrome 

    46. Galactokinase deficiency 

    47. Granulomatous lobular mastitis 

    48. Hand foot uterus syndrome 

    49. HELLP syndrome 

    50. Hydatidiform mole 

    51. Intrahepatic cholestasis of pregnancy 

    52. Kallmann syndrome 

    53. Kallmann syndrome 1 

    54. Laurence-Moon syndrome 

    55. Limb-mammary syndrome 

    56. Lynch syndrome - Not a rare disease 

    57. Male pseudohermaphroditism intellectual disability syndrome, Verloes type 

    58. Martsolf syndrome 

    59. McCune-Albright syndrome 

    60. Meacham Winn Culler syndrome 

    61. Metaplastic carcinoma of the breast 

    62. MPI-CDG (CDG-Ib) 

    63. MURCS association 

    64. Ovarian carcinosarcoma 

    65. Paget disease of the breast 

    66. PAGOD syndrome 

    67. Panhypopituitarism X-linked 

    68. Partial androgen insensitivity syndrome 

    69. Peripartum cardiomyopathy 

    70. Perrault syndrome 

    71. Poland syndrome 

    72. Polycystic ovarian syndrome

    73. Primary pigmented nodular adrenocortical disease

    74. Pruritic urticarial papules plaques of pregnancy

    75. Rare adenocarcinoma of the breast

    76. Satoyoshi syndrome 

    77. Scalp ear nipple syndrome 

    78. Schaaf-Yang syndrome 

    79. Sickle beta thalassemia 

    80. Sickle cell anemia

    81. Spinal Muscular Atrophy 

    82. Spondyloepiphyseal dysplasia tarda X-linked 

    83. Swyer syndrome 

    84. Tetrasomy X 

    85. Ulnar-mammary syndrome 

    86. Uterine Carcinosarcoma 

    87. WAGR syndrome 

    88. Woodhouse Sakati syndrome 

    89. X-linked adrenal hypoplasia congenita,...  

​

  • Elsee Medicine Reproductive Health Genomic Test reports provide valuable information for prevention, screening, and treatment of genetic reproductive and fertility disorders.

bottom of page